D-0834-2020 Class II Terminated
FDA drug recall D-0834-2020 was initiated by Zydus Pharmaceuticals USA Inc on Jan 31, 2020 and is designated Class II. Reason for recall: cGMP Deviations The recall status is terminated (terminated Oct 26, 2021). Affected quantity: 2207 Vials.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 19, 2020
- Initiation Date
- Jan 31, 2020
- Termination Date
- Oct 26, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2207 Vials
Product description
Ethacrynate Sodium for Injection, USP, 50mg/vial, Single Dose Vial, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-246-01.
Reason for recall
cGMP Deviations
Distribution pattern
Nationwide in the U.S.
Code information
Lot #s: M804062, Exp. 01/2020; M804063, M804064, Exp. 02/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0834-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026